MLZE Antikörper (AA 1-100) (Cy5)
Kurzübersicht für MLZE Antikörper (AA 1-100) (Cy5) (ABIN6984263)
Target
Alle MLZE Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-100
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human GSDMC
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- MLZE (Melanomaderived Leucine Zipper Extra-Nuclear Factor (MLZE))
-
Andere Bezeichnung
- GSDMC
-
Hintergrund
-
Synonyms: Gasdermin C, Gasdermin-C, GSDMC, GSDMC_HUMAN, Melanoma derived leucine zipper, extra nuclear factor, Melanoma-derived leucine zipper-containing extranuclear factor, MLZE
Background: The N-terminal moiety promotes pyroptosis. May be acting by homooligomerizing within the membrane and forming pores (PubMed:27281216). The physiological relevance of this observation is unknown (Probable).
-
Gen-ID
- 56169
-
UniProt
- Q9BYG8
Target
-